News | Interventional Radiology | April 21, 2020

Guerbet Announces FDA Approval to Manufacture Dotarem Injection in the United States

#gadolinium Guerbet announced that it received U.S. Food and Drug Administration (FDA) approval to manufacture Dotarem (gadoterate meglumine) injection at its Raleigh, N.C., facility

April 21, 2020 — Guerbet announced that it received U.S. Food and Drug Administration (FDA) approval to manufacture Dotarem (gadoterate meglumine) injection at its Raleigh, N.C., facility. Until late 2019, Dotarem was manufactured exclusively outside of the United States. 

Guerbet intends to produce Dotarem within the United States for US-based customers, in alignment with Guerbet’s broader vision to supply US-manufactured products to US customers. Guerbet’s line of power injectors and urology systems are manufactured and/or assembled in Cincinnati, Ohio.

“We are proud to add Dotarem to our list of products manufactured or assembled in the United States for US customers,” reported Thomas McLaughlin, vice president, North America. The Raleigh facility is manufacturing Dotarem  in both vials and plastic syringes. The plastic syringes feature a new pushrod that is designed to make hand injections more ergonomic, and plastic pre-filled syringes reduce patient risks including the chance of contamination as compared to bulk fill containers. The StarClip adapter enables power injection of Dotarem (in the new plastic syringes) using Guerbet’s OptiStar Elite injector. The new, more durable outer packaging allows for both improved convenience and workflow efficiency in the radiology suite.

As a result of U.S. manufacturing approval, customers should refer to the following new product item numbers and NDC codes when ordering new product inventory:

For Dotarem® 10x15mL Vials:
New Item Code: 368220012
New NDC Code: 67684200102

For Dotarem 10x100mL Vials:
New Item Code: 368220014
New NDC Code: 67684200104

For Dotarem 10x20mL Vials:
New Item Code: 368220013
New NDC Code: 67684200103

For Dotarem 20mL Plastic Prefilled Syringe:
New Item Code: 368230013
New NDC Code: 67684300103

All units of measure remain the same except for the Prefilled Syringe (PFS) product line, which has changed from 5/box to 10/case.

These are the first of several SKUs to launch in the U.S. Remaining SKUs will be phased in throughout 2020.

Customers are encouraged to continue using their existing supply of glass syringes with Dotaclip as new syringes with StarClip are introduced. Customers should work with their distribution partners to ensure that correct products are received throughout this transition process.

For more information: www.guerbet.com

Related Content

World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO | July 09, 2020
July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (...
Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more deaths, but with more testing and emotional stress

Getty Images

News | Breast Imaging | July 09, 2020
July 9, 2020 — Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metast
At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review. 
Feature | Treatment Planning | July 08, 2020 | By Melinda Taschetta-Millane
At the American Association of Physicists in Medicine (AAPM) 201
 Many patients with severe coronavirus disease 2019 (COVID-19) remain unresponsive after surviving critical illness. Investigators led by a team at Massachusetts General Hospital (MGH) now describe a patient with severe COVID-19 who, despite prolonged unresponsiveness and structural brain abnormalities, demonstrated functionally intact brain connections and weeks later he recovered the ability to follow commands

Getty Images

News | Coronavirus (COVID-19) | July 08, 2020
July 8, 2020 — Many patients with severe coronavirus disease 2019 (...
Changes outlined in new draft U.S. Preventive Services Task Force (USPSTF) lung cancer screening recommendations will greatly increase the number of Americans eligible for screening and help medical providers save thousands more lives each year.

Image courtesy of Cerner

News | Lung Imaging | July 08, 2020
July 8, 2020 — Changes outlined in new draft U.S.
Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.
Feature | Radiation Therapy | July 06, 2020 | By Yves Archambault
Everything has room for improvement, right? Right. When it comes to cancer care, it is no different.
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam
Feature | Proton Therapy | July 06, 2020 | By Minesh Mehta, M.D.
The field of proton...
A patient implanted with the Axonics System can undergo MRI examinations safely with radio frequency (RF) Transmit Body or Head Coil under the conditions outlined in the Axonics MRI Conditional Guidelines.

A patient implanted with the Axonics System can undergo MRI examinations safely with radio frequency (RF) Transmit Body or Head Coil under the conditions outlined in the Axonics MRI Conditional Guidelines.

News | Magnetic Resonance Imaging (MRI) | July 02, 2020
July 2, 2020 — Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commerci
This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
Researchers reviewed results of prostate biopsies on over 3,400 men who had targets identified on prostate MRI and found that the positive predictive value of the test for prostate cancer was highly variable at different sites
News | Prostate Cancer | July 01, 2020
July 1, 2020 — Prostate MRI is an emerging technology used to identify and guide treatment for...